According to GlaxoSmithKline's latest financial reports the company has $16.71 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $16.28 B | 33.11% |
2022-12-31 | $12.23 B | -57.52% |
2021-12-31 | $28.80 B | 1.57% |
2020-12-31 | $28.36 B | 17.83% |
2019-12-31 | $24.07 B | 416.44% |
2018-12-31 | $4.66 B | -1.16% |
2017-12-31 | $4.71 B | -23.06% |
2016-12-31 | $6.12 B | -53.42% |
2015-12-31 | $13.15 B | 71.2% |
2014-12-31 | $7.68 B | -40.36% |
2013-12-31 | $12.88 B | 18.34% |
2012-12-31 | $10.88 B | -20.47% |
2011-12-31 | $13.69 B | -8.98% |
2010-12-31 | $15.04 B | -13.46% |
2009-12-31 | $17.38 B | 42.59% |
2008-12-31 | $12.19 B | -38.13% |
2007-12-31 | $19.70 B | 4.02% |
2006-12-31 | $18.94 B | 45.6% |
2005-12-31 | $13.01 B | 10.24% |
2004-12-31 | $11.80 B | -21.96% |
2003-12-31 | $15.12 B | 63.17% |
2002-12-31 | $9.26 B | -12.02% |
2001-12-31 | $10.53 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Novartis NVS | $39.75 B | 137.81% | ๐จ๐ญ Switzerland |
Pfizer PFE | $89.28 B | 434.09% | ๐บ๐ธ USA |
Sanofi SNY | $82.20 B | 391.71% | ๐ซ๐ท France |
Merck MRK | $37.63 B | 125.12% | ๐บ๐ธ USA |
AstraZeneca AZN | $37.50 B | 124.32% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $8.12 B | -51.39% | ๐ฎ๐ฑ Israel |
Dynavax Technologies
DVAX | $0.62 B | -96.28% | ๐บ๐ธ USA |